^
    Apply
    Autologous Memory-like NK Cell Therapy With BHV-1100 (Formerly KP1237), Low Dose IL-2 in Multiple Myeloma Patients (NCT04634435)
    Phase 1
    Biohaven Pharmaceuticals, Inc.
    Recruiting
    Last update posted :
    08/29/2023
    Initiation :
    10/21/2021
    Primary completion :
    10/01/2025
    Completion :
    10/01/2026
    CD34
    |
    BHV-1100 • CIML NK